hotspot -WSS

hotspot

author：leisure time 2025-09-30 16:29:00 - browse：83

Vertex Pharmaceuticals Inc. building — Craig F. Walker/The Boston Globe

Vertex Pharmaceuticals said Friday that, over a year after receiving the company’s stem-cell therapy, two type 1 diabetes patients no longer need to take insulin injections and saw stark reductions in a biological marker of disease.

The results, presented at the American Diabetes Association conference in San Diego, bolstered experts’ hopes that the treatment could provide a functional cure for some patients. In 2021, Vertex announced dramatic results from the first man to receive the treatment, but researchers cautioned it was just one person, who had only been followed for 90 days.

“The data look as good as they could be,” said Jeanne Loring, a stem cell expert and professor emeritus at Scripps Research not involved in the work, in an email.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： At least 13 dead in Texas as scorching temps continue
Next article： AI generated plenty of interest at JPM but not a lot of trust

leisure time

WSS

Giant panda gives birth to squirming, squealing healthy twin girls at South Korean theme park

Sickle cell gene therapy cures need to be accessible in Africa

Va. Republicans encourage early voting, a target of Trump's, ahead of fall elections

Blinken talks high

Watch the official trailer for 'Ahsoka' series

How digital therapeutics firms are pivoting after Pear's bankruptcy

knowledge

hotspot

focus

Guidelines to prevent youth baseball injuries need more muscle

Grail's uphill battle for Medicare to cover its cancer screening test

Medical leaders decry Supreme Court decision on affirmative action

Independent physicians launch a new lobbying group

Wildfire smoke exposes gaps in outdoor worker protections

Eli Lilly, Pfizer, and others want in on the online prescription market

Continuity nursing helped my family in our darkest PICU moments

Britney Spears to release memoir, 'The Woman In Me,' later this year

Malaria cases in Florida and Texas: Here’s what you need to know

What to make of Gilead’s Trodelvy troubles and Elevation Oncology’s rise

hotspot

Is there an 'orca uprising'? Like orcas themselves, the answer is complex.

Grail's uphill battle for Medicare to cover its cancer screening test

Gilead’s Trodelvy fails in lung cancer, raises questions on ADCs

Is there an 'orca uprising'? Like orcas themselves, the answer is complex.

New brain studies show LSD's effects on the brain in full color

One Duchenne patient's bittersweet hope for new treatment

leisure time

hotspot

explore

knowledge